Mergers & Acquisitions
A group of investors has been designated as the winning bidder to acquire substantially all of Exactech’s assets.
Amplitude Surgical develops and markets orthopedic implants, covering the main pathologies affecting the hip and knee.
February 27, 2025
,
Julie A. Vetalice
February 12, 2025
,
Julie A. Vetalice
Stryker divested the majority of its spinal implant business while Zimmer Biomet agreed to acquire foot-and-ankle player Paragon 28.
January 30, 2025
,
Paragon 28 has a suite of surgical offerings and product systems spanning all major foot and ankle segments, including fracture and trauma, deformity correction and joint replacement.
January 29, 2025
,
The U.S. implants business will be sold to Viscogliosi Brothers. Plans follow to sell the related international spine business.
January 29, 2025
,
Anika plans to focus on its core hyaluronic acid technology and advance its differentiated Regenerative Solutions portfolio.
October 31, 2024
,
Vertos Medical offers interventional pain management solutions for chronic lower back pain caused by lumbar spinal stenosis.
October 1, 2024
,
The integration brings offerings for joint replacement, spine, trauma, sports medicine, robotics and more.
September 20, 2024
,
Stryker expanded its foot & ankle portfolio with the purchase of 4WEB’s Osteotomy Truss and Ankle Truss systems.
September 11, 2024
,
Vertos Medical has developed mild, a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis.
August 22, 2024
,
The acquisition includes OrthoGrid’s fluoroscopy-based Hip AI surgical assistance platform, as well as two additional FDA-cleared orthopedic applications.
August 7, 2024
,
Artelon is a specialist in soft tissue fixation products for foot and ankle and sports medicine procedures.
June 3, 2024
,
This technology has been shown to grow bone rapidly in vivo without inducing bone synthesis at ectopic sites by non-bone cells.
May 7, 2024
,
The company seeks to sell its Poly-gamma-glutamic Acid technology related to OA, plus various intellectual property and know-how assets.
April 30, 2024
,
The acquired business will operate as an independent entity and has been renamed Highridge Medical.
April 1, 2024
,
The acquisition will leverage Innosys’ R&D in the spine segment, synergizing with CG Bio’s orthobiologic and spinal devices.
February 27, 2024
,
Zeda will produce OIC’s implant designs, fortifying and accelerating its mission to provide accessible trauma implants to patients on a worldwide scale.
